Kate Brettingham-Moore
Kate Brettingham-Moore
Lecturer, School of Medicine, University of Tasmania
Verified email at utas.edu.au
Title
Cited by
Cited by
Year
Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere
LH Wong, KH Brettingham-Moore, L Chan, JM Quach, MA Anderson, ...
Genome research 17 (8), 1146-1160, 2007
2772007
Correction: LINE Retrotransposon RNA Is an Essential Structural and Functional Epigenetic Component of a Core Neocentromeric Chromatin
AC Chueh, EL Northrop, KH Brettingham-Moore, KHA Choo, LH Wong
PLoS genetics 5 (2), 2009
1632009
LINE retrotransposon RNA is an essential structural and functional epigenetic component of a core neocentromeric chromatin
AC Chueh, EL Northrop, KH Brettingham-Moore, KHA Choo, LH Wong
PLoS genetics 5 (1), e1000354, 2009
1632009
Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.
KH Brettingham-Moore, CP Duong, DM Greenawalt, AG Heriot, J Ellul, ...
Clinical cancer research, clincanres. 2915.2010, 2011
572011
GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements
KH Brettingham-Moore, S Rao, T Juelich, MF Shannon, AF Holloway
Nucleic acids research 33 (1), 225-234, 2005
422005
RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization
A Young, R Berry, AF Holloway, NB Blackburn, JL Dickinson, M Skala, ...
BMC cancer 14 (1), 808, 2014
402014
Using gene expression profiling to predict response and prognosis in gastrointestinal cancers—the promise and the perils
KH Brettingham-Moore, CP Duong, AG Heriot, RJS Thomas, WA Phillips
Annals of surgical oncology 18 (5), 1484-1491, 2011
342011
Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia
KH Brettingham-Moore, PC Taberlay, AF Holloway
Frontiers in immunology 6, 499, 2015
322015
Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil
AL Patchett, R Latham, KH Brettingham-Moore, C Tovar, AB Lyons, ...
Developmental & Comparative Immunology 53 (1), 123-133, 2015
192015
Determinants of a transcriptionally competent environment at the GM-CSF promoter
KH Brettingham-Moore, OR Sprod, X Chen, P Oakford, MF Shannon, ...
Nucleic acids research 36 (8), 2639-2653, 2008
182008
Molecular changes in the phosphatidylinositide 3‐kinase (PI3K) pathway are common in gastric cancer
TN Tran, K Brettingham‐Moore, CP Duong, C Mitchell, NJ Clemons, ...
Journal of surgical oncology 108 (2), 113-120, 2013
132013
mRNA gene expression correlates with histologically diagnosed chemotherapy‐induced hepatic injury
CHC Pilgrim, K Brettingham‐Moore, A Pham, W Murray, E Link, M Smith, ...
HPB 13 (11), 811-816, 2011
112011
Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells
JL Phillips, PC Taberlay, AM Woodworth, K Hardy, ...
Journal of cellular physiology 233 (4), 3439-3453, 2018
102018
Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activation
FS Poke, WR Upcher, OR Sprod, A Young, KH Brettingham-Moore, ...
PloS one 7 (7), e41734, 2012
92012
DNA methylation changes following DNA damage in prostate cancer cells
LP Sutton, SA Jeffreys, JL Phillips, PC Taberlay, AF Holloway, M Ambrose, ...
Epigenetics, 1-14, 2019
72019
Cancer Epigenetics
KH Brettingham-Moore, PC Taberlay
Drug Discovery in Cancer Epigenetics, 41-59, 2016
52016
The leukemia inhibitory factor receptor gene is a direct target of RUNX1
AA Qadi, PC Taberlay, JL Phillips, A Young, AC West, ...
Journal of cellular biochemistry 117 (1), 49-58, 2016
42016
Chromatin Remodelling: Distinct molecular events during differentiation and activation of T cells
FM Shannon, X Chen, K Brettingham-Moore, A Holloway
Current Immunology Reviews 2 (3), 273-289, 2006
12006
Mrna Gene Expression Correlates With Histological Injury Associated With Chemotherapy
CH Pilgrim, W Phillips, B Thomson, S Banting, K Brettingham-moore, ...
The Official Journal of The International Hepato Pancreato Biliary …, 2011
2011
Defining the molecular events required for GM-CSF gene activation in T cells
K Brettingham-Moore
University of Tasmania, 2007
2007
The system can't perform the operation now. Try again later.
Articles 1–20